WASHINGTON, DC, July 22, 2015 - The Alzheimer's Association is recognizing Ralph A. Nixon, M.D., Ph.D., Professor of Psychiatry and Cell Biology at New York University Langone Medical Center in New York City and Director of Research and of the Center for Dementia Research at the Nathan Kline Institute in Orangeburg, NY, with the Zaven Khachaturian Award for his achievement in advancing the field of Alzheimer's disease science. The Award was presented today during a plenary session at the Alzheimer's Association International Conference® 2015 (AAIC® 2015) in Washington, D.C.
Dr. Nixon's pioneering research into the early brain changes associated with Alzheimer's disease, including the abnormal breakdown of proteins, has helped scientists better understand the process by which Alzheimer's develops and progresses. His research has helped identify new avenues for investigating potential Alzheimer's disease therapies.
"The effect Dr. Nixon's research has and will have on scientists' understanding of Alzheimer's disease is profound," said Maria Carrillo, Ph.D., chief science officer for the Alzheimer's Association. "We honor Dr. Nixon's commitment to Alzheimer's research, to the Alzheimer's Association and the entire scientific community."
Dr. Nixon sits on the editorial boards of numerous scientific journals and has published more than 270 scientific papers. He served as chair of the Alzheimer's Association Medical and Scientific Advisory Council from 2013 to 2015 and has been a member and chair of multiple National Institutes of Health scientific review committees. He is currently a member of the Association's National Board of Directors and the Governor's Commission on Alzheimer's Disease for New York State.
The Zaven Khachaturian Award was established in honor of Zaven Khachaturian, Ph.D., whose compelling vision, selfless dedication and most extraordinary achievement has significantly advanced the field of Alzheimer's disease science.
The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease and to recognizing the efforts of researchers who further our understanding about this devastating disease. The Association is the largest nonprofit funder of Alzheimer's research. It currently supports nearly 350 ongoing research projects in 21 countries, totaling over $78 million. Since 1982, it has awarded nearly $340 million to almost 2,300 scientific investigations.
The Alzheimer's Association International Conference (AAIC) is the largest gathering of leading researchers from around the world focused on Alzheimer's and other dementias. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.?
About the Alzheimer's Association®
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. Visit alz.org or call 800.272.3900.